Global Anti-Infective Drugs Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

29 Apr, 2021

The anti-infective drugs market consists of sales of branded and generic anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-infective drugs to treat microbial infections. The anti-infective drugs industry includes establishments that manufacture antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti-helminthic drugs to kill internal parasites, and antiprotozoal agents to treat protozoan infections.

Global Anti-Infective Drugs Market Size And Drivers:

The global anti-infective drugs market is expected to decline from $132.16 billion in 2020 to $116.4 billion in 2021 at a compound annual growth rate (CAGR) of -11.9%. The market is expected to reach $158.29 billion in 2025 at a CAGR of 8%.

The wide adoption of these technologies is expected to drive the anti-infective drugs market in the forecast period.

Request For A Sample For The Global Anti-Infective Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3604&type=smp

Trends In The Global Anti-Infective Drugs Market

Anti-infective drug manufacturers are investing in programs to develop drugs to treat drug resistant infections. Antimicrobial resistance is a serious concern to global public health as it resulted in long duration of illness, the requirement of additional tests and use of more expensive drugs. Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, parasites and fungi change and adapted to drugs when they are exposed to antimicrobial drugs such as antibiotics, antivirals, antifungals, anthelmintics and others. According to World Health Organization (WHO), globally 4, 80,000 people are being affected by multi-drug resistant TB each year and drug resistance is starting to complicate the treatment of malaria and HIV as well. Companies are investing in developing the new drug candidates to treat drug-resistant infections.

Global Anti-Infective Drugs Market Segments:
The global anti-infective drugs market is further segmented based on type, distribution channel, route of administration, drug classification, mode of purchase and geography.
By Type: Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal).
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others.
By Route Of Administration: Oral, Parenteral, Others.
By Drug Classification: Branded Drugs, Generic Drugs.
By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
By Geography: The global anti-infective drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Among these regions, North America is the largest region in the global anti-infective drugs market, accounting for 50% of the market.

Read More On The Report For The Global Anti-Infective Drugs Market At:

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report

Anti-Infective Drugs Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides anti-infective drugs market overviews, analyzes and forecasts market size and growth for the global anti-infective drugs market, anti-infective drugs market share, anti-infective drugs market players, anti-infective drugs market segments and geographies, anti-infective drugs market’s leading competitors’ revenues, profiles and market shares. The anti-infective drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.